Baichun Yang

Summary

Affiliation: GlaxoSmithKline Research and Development
Country: USA

Publications

  1. Yang B, Brown K, Chen L, Carrick K, Clifton L, McNulty J, et al. Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats. BMC Pharmacol. 2004;4:23 pubmed
    ..These data suggest that serum adiponectin can serve as a biomarker for both in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin resistance and dyslipidemia in rats. ..
  2. Yang B, Lin P, Carrick K, McNulty J, Clifton L, Winegar D, et al. PPARgamma agonists diminish serum VEGF elevation in diet-induced insulin resistant SD rats and ZDF rats. Biochem Biophys Res Commun. 2005;334:176-82 pubmed
    ....

Detail Information

Publications2

  1. Yang B, Brown K, Chen L, Carrick K, Clifton L, McNulty J, et al. Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats. BMC Pharmacol. 2004;4:23 pubmed
    ..These data suggest that serum adiponectin can serve as a biomarker for both in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin resistance and dyslipidemia in rats. ..
  2. Yang B, Lin P, Carrick K, McNulty J, Clifton L, Winegar D, et al. PPARgamma agonists diminish serum VEGF elevation in diet-induced insulin resistant SD rats and ZDF rats. Biochem Biophys Res Commun. 2005;334:176-82 pubmed
    ....